Skip to main content
$6.79 $0.14 (2.1%)

04:00 PM EST on 12/01/20

Cerus Corp (NASDAQ:CERS)

CAPS Rating: 2 out of 5

The Company develops and commercializes novel, proprietary products and technologies within the fields of blood safety and immunotherapy that provides safer and more medical options to patients in areas of unmet medical need.

Current Price $6.79 Mkt Cap $1.1B
Open $6.73 P/E Ratio 0.00
Prev. Close $6.65 Div. (Yield) $0.00 (0.0%)
Daily Range $6.68 - $7.00 Volume 2,597,329
52-Wk Range $2.71 - $7.94 Avg. Daily Vol. 1,494,232

Caps

How do you think NASDAQ:CERS will perform against the market?

Add Stock to CAPS Watchlist

All Players

143 Outperform
15 Underperform
 

All-Star Players

11 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CERS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

flstfi88 (< 20)
Submitted April 26, 2010

The Intercept system will be approved by the FDA for the US and this will become very profitable.

zzlangerhans (97.67)
Submitted November 29, 2015

The biotech sector rebound is lifting up a lot of stocks that have been unfairly beaten down, and some others like Cerus whose weakness was more deserved. Revenues have been stagnant this year, which management initially blamed on the Euro and more… More

Recent Community Commentary

Read the most recent pitches from players about CERS.

Recs

0
Member Avatar sk2129 (31.09) Submitted: 11/30/2015 4:37:56 PM : Outperform Start Price: $4.49 NASDAQ:CERS Score: -19.88

baker bros.

Recs

0
Member Avatar Saveupnow (< 20) Submitted: 2/13/2014 2:25:47 PM : Outperform Start Price: $7.29 NASDAQ:CERS Score: -105.00

FDA approval expected this year, need cleaner blood and plasma

Recs

0
Member Avatar IFindKaching (< 20) Submitted: 4/18/2011 12:38:26 PM : Outperform Start Price: $2.74 NASDAQ:CERS Score: -28.35

CERS is the best option in the critical market for blood supply protection. Already accepted in Europe and other parts of the world, it's only a matter of time for FDA approval in the US. When that happens...

Leaderboard

Find the members with the highest scoring picks in CERS.

Score Leader

NatedoggGT1

NatedoggGT1 (89.59) Score: +177.34

The Score Leader is the player with the highest score across all their picks in CERS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
NatedoggGT1 89.59 10/16/2007 4/14/2008 Underperform 3Y $9.71 -28.68% +148.66% +177.34 0 Comment
ericsmu 42.07 10/4/2006 Underperform 3W $5.60 +23.66% +188.80% +165.14 0 Comment
BicaChica 80.82 3/26/2008 Underperform 5Y $5.86 +18.17% +183.30% +165.13 0 Comment
FundamentalGamma < 20 12/10/2007 Underperform NS $6.96 -0.50% +153.36% +153.86 1 Comment
MassProduced 92.12 2/16/2007 Underperform NS $5.52 +25.45% +166.98% +141.53 0 Comment
hayrettin 71.61 7/27/2017 Outperform 5Y $2.40 +188.54% +48.32% +140.22 0 Comment
ahknaten74 94.63 3/24/2008 Underperform NS $4.79 +44.57% +184.59% +140.02 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. chammond55 98.88 6/2/2017 Outperform 5Y $2.41 +187.34% +50.09% +137.26 0 Comment
clover0958 69.53 5/9/2007 Underperform 3M $5.77 +20.02% +156.50% +136.48 0 Comment
mifollower 22.59 1/21/2011 Underperform NS $3.59 +92.90% +183.86% +90.96 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CERS.